Search and Filter
Results per Page:
Strengthening cancer care by building trust and community
10th annual Pathways to Health Symposium highlights projects, best practices for expanding care throughout Washington state
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research
Hematology-oncology fellows and faculty receive $50,000 each toward early-career projects
Oncology Insights with Dr. Petros Grivas - Episode 14
Dr. Sara Hurvitz on clinical trials, multidisciplinary care and leadership in oncology
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better
Confused about cancer? 1.800.4.CANCER is here to help
The taxpayer-supported National Cancer Institute contact center is based at Fred Hutch Cancer Center
Fred Hutch hematologists featured at 2026 Tandem Meetings
Researchers highlight findings on making stem cell transplants safer and more effective
Brandeis University honors Fred Hutch molecular biologist
Dr. Steven Henikoff receives 55th Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research
Dr. Heather Parsons to lead Fred Hutch’s breast cancer initiatives
Medical oncologist awarded endowed chair to study novel markers for cancer in blood serum
Two lifetimes’ worth of bone marrow transplant breakthroughs
Bone marrow transplant pioneer Dr. Rainer Storb retires and reflects on six decades of science and mentorship
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
$600,000 in awards against ovarian cancer for Fred Hutch and UW researchers
Research awarded from the Rivkin Center and Andy Hill CARE fund will dramatically improve outcomes for ovarian cancer patients and the clinicians treating them
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Dr. Sara Hurvitz receives the Smith Family Endowed Chair in Women’s Health
Flexible funding will fuel physician-scientist’s work to improve survivorship for women with cancer
Surprising findings about blood cell mutations bode well for transplant recipients
Fred Hutch researchers compared blood samples from 16 recipient-donor pairs, some more than 45 years after transplant
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Fred Hutch Phase 1 Program director, Dr. John Thompson, retires
An immunotherapy champion, Thompson co-led the melanoma clinic for decades
A charming model: new tool evaluates risk of transplant for older patients
Seven values are evaluated to predict outcomes
New funding drives six breast cancer studies
Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation